Key result
Poldip2 deficiency impairs postischemic limb perfusion recovery and reduces functional running distance by ~25%.
Why the study?
Polymerase δ-interacting protein 2 (Poldip2) regulates focal adhesion turnover, vascular smooth muscle cell migration, and extracellular matrix composition, prompting evaluation of whether loss of Poldip2 impairs postischemic collateral vessel formation.
Does heterozygous loss of Polymerase δ-interacting protein 2 (Poldip2) impair ischemia-induced collateral vessel formation and functional recovery in a mouse model of hindlimb ischemia?
Does heterozygous loss of Polymerase δ-interacting protein 2 (Poldip2) impair ischemia-induced collateral vessel formation and functional recovery in a mouse model of hindlimb ischemia?
Answers are grounded in this paper and cite their sources.
Poldip2 is essential for postischemic collateral vessel formation and limb functional recovery in mice through mechanisms involving ROS production, MMP activation, and vascular cell proliferation and survival.
OBJECTIVE: Collateral vessel formation can functionally compensate for obstructive vascular lesions in patients with atherosclerosis. Neovascularization processes are triggered by fluid shear stress, hypoxia, growth factors, chemokines, proteases, and inflammation, as well as reactive oxygen species, in response to ischemia. Polymerase δ-interacting protein 2 (Poldip2) is a multifunctional protein that regulates focal adhesion turnover and vascular smooth muscle cell migration and modifies extracellular matrix composition. We, therefore, tested the hypothesis that loss of Poldip2 impairs collateral formation. APPROACH AND RESULTS: The mouse hindlimb ischemia model has been used to understand mechanisms involved in postnatal blood vessel formation. Poldip2(+/-) mice were subjected to femoral artery excision, and functional and morphological analysis of blood vessel formation was performed after injury. Heterozygous deletion of Poldip2 decreased the blood flow recovery and spontaneous running activity at 21 days after injury. H2O2 production, as well as the activity of matrix metalloproteinases-2 and -9, was reduced in these animals compared with Poldip2(+/+) mice. Infiltration of macrophages in the peri-injury muscle was also decreased; however, macrophage phenotype was similar between genotypes. In addition, the formation of capillaries and arterioles was impaired, as was angiogenesis, in agreement with a decrease in proliferation observed in endothelial cells treated with small interfering RNA against Poldip2. Finally, regression of newly formed vessels and apoptosis was more pronounced in Poldip2(+/-) mice. CONCLUSIONS: Together, these results suggest that Poldip2 promotes ischemia-induced collateral vessel formation via multiple mechanisms that likely involve reactive oxygen species-dependent activation of matrix metalloproteinase activity, as well as enhanced vascular cell growth and survival.
No takes yet. Share an insight, caveat, or question.
Amanso et al. (2014) studied Postischemic hindlimb neovascularization / peripheral arterial obstructive disease model. Heterozygous deletion of Poldip2 (Poldip2+/-) vs. Wild-type (Poldip2+/+) mice subjected to femoral artery ligation and excision was evaluated on Functional blood flow recovery (Laser Doppler Perfusion Imaging) and voluntary running wheel distance at 21 days. Heterozygous deletion of Poldip2 impaired postischemic blood flow recovery, caused 50±5% vascular regression, and reduced voluntary running distance by 25% at 21 days compared to wild-type mice.
Synapse has enriched 10 related papers. Consider them for comparative context: